| 141 |
Jason Kindrachuk, University of Manitoba, Canada |
Jason Kindrachuk, University of Manitoba, Canada |
|
| 142 |
Otfried Kistner, Senior Consultant and Independent Vaccine Expert, Austria |
Otfried Kistner, Senior Consultant and Independent Vaccine Expert, Austria |
|
| 143 |
Gary Kobinger, Université Laval, Canada |
Gary Kobinger, Université Laval, Canada |
|
| 144 |
Marion Koopmans, Viroscience Department, Erasmus Medical Centre, The Netherlands |
Marion Koopmans, Viroscience Department, Erasmus Medical Centre, The Netherlands |
|
| 145 |
Philip R. Krause, Food and Drug Administration, U.S. Department of Health and Human Services, USA |
Philip R. Krause, Food and Drug Administration, U.S. Department of Health and Human Services, USA |
|
| 146 |
Greg Kulnis, Nexelis, Canada |
Greg Kulnis, Nexelis, Canada |
|
| 147 |
Paul Henri Lambert, Centre of Vaccinology, University of Geneva, Switzerland |
Paul Henri Lambert, Centre of Vaccinology, University of Geneva, Switzerland |
|
| 148 |
Nathalie Landry, Medicago Inc., Canada |
Nathalie Landry, Medicago Inc., Canada |
|
| 149 |
Roger Le Grand, Inserm-CEA-Université Paris Saclay, France |
Roger Le Grand, Inserm-CEA-Université Paris Saclay, France |
|
| 150 |
Robin Levis, Food and Drug Administration, U.S. Department of Health and Human Services, USA |
Robin Levis, Food and Drug Administration, U.S. Department of Health and Human Services, USA |
|